KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Merck (MRK) Equity Ratio (2016 - 2025)

Historic Equity Ratio for Merck (MRK) over the last 17 years, with Q3 2025 value amounting to 0.4.

  • Merck's Equity Ratio rose 568.49% to 0.4 in Q3 2025 from the same period last year, while for Sep 2025 it was 0.4, marking a year-over-year increase of 568.49%. This contributed to the annual value of 0.4 for FY2024, which is 1223.99% up from last year.
  • According to the latest figures from Q3 2025, Merck's Equity Ratio is 0.4, which was up 568.49% from 0.42 recorded in Q2 2025.
  • Merck's Equity Ratio's 5-year high stood at 0.44 during Q1 2023, with a 5-year trough of 0.3 in Q1 2021.
  • Moreover, its 5-year median value for Equity Ratio was 0.39 (2023), whereas its average is 0.39.
  • Per our database at Business Quant, Merck's Equity Ratio surged by 3049.6% in 2021 and then crashed by 1638.43% in 2023.
  • Over the past 5 years, Merck's Equity Ratio (Quarter) stood at 0.36 in 2021, then increased by 16.57% to 0.42 in 2022, then decreased by 16.38% to 0.35 in 2023, then rose by 12.24% to 0.4 in 2024, then grew by 1.19% to 0.4 in 2025.
  • Its last three reported values are 0.4 in Q3 2025, 0.42 for Q2 2025, and 0.42 during Q1 2025.